KADCYLA TRASTUZUMAB EMTANSINE
Mark Identification

KADCYLA TRASTUZUMAB EMTANSINE

Serial Number

85163833

Filing Date

Oct 28, 2010

Trademark by

GENENTECH INC.

Classification Information

Pharmaceutical preparations containing trastuzumab emtansine for treatment of cardiovascular diseases and disorders, oncological diseases and disorders, immune diseases and disorders, angiogenesis diseases and disorders, ocular diseases and disorders, inflammatory diseases and disorders, gastro-intestinal diseases and disorders, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, metabolic diseases and disorders

Pharmaceuticals

Providing educational training in the medical field

Education and Entertainment